Numab Therapeutics
Pfäffikon, Switzerland· Est.
Numab Therapeutics designs and develops multispecific antibody therapeutics for oncology and immunology using its proprietary antibody engineering platform.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $50M
About
Numab Therapeutics designs and develops multispecific antibody therapeutics for oncology and immunology using its proprietary antibody engineering platform.
AntibodiesOncologyImmunology
Funding History
1Total raised:$50M
Series C$50M